Find an Eye MD near you!

Eyegate Pharmaceuticals announced promising interim data showing iontophoresis can non-invasively deliver dexamethasone phosphate to the posterior segment.

The authors of this randomized trialfound that neither cataract surgery nor IOL type have a significant impact on circadian photoentrainment or sleep quality.

Allergan announced it will develop and commercialize dry eye drug tavilermide through an exclusive licensing agreement with Mimetogen Pharmaceuticals.

Researchers have identified a steroid that has the potential to reverse cataracts by blocking α-crystallin aggregation.

Study finds that glaucoma patients are at higher risk for complications and show weaker visual improvement.

AGTC has filed a new drug application with the FDA to conduct a clinical trial of a gene therapy product to treat achromatopsia.